Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Updated June 10th, 2021

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
New Hope For Patients with Cervical Cancer
NOW
PLAYING
Sherry Pollex Promotes Ovarian Cancer Awareness at NASCAR Race
NOW
PLAYING
September is Ovarian Cancer Awareness Month; ‘Exciting’ Advancements in Treating this Cancer Have Been Made in Recent Years
NOW
PLAYING
A Leukemia Patient Unable to Get Vaccinated Has Died from COVID at 41; Should People with Blood Cancer Get the Vaccine?
NOW
PLAYING
Cancer Survivor in Late Stage Battle With Disease After COVID Delays
NOW
PLAYING
COVID Vaccines Are Far Less Effective in Most Cancer Patients, Ineffective in Some, According to New Research

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.